ChEMBL logo

ChEMBL

spacer
ChEMBL Statistics
  Loading Statistics...
spacer

Compound Report Card

Compound Name and Classification

Compound ID CHEMBL461101
CHEMBL461101
Compound Name ELTROMBOPAG
ChEMBL Synonyms ELTROMBOPAG OLAMINE | ELTROMBOPAG | Revolade | SB-497115-GR | PROMACTA | Promacta | REVOLADE | Eltrombopag olamine
Max Phase 4 (Approved)
Trade Names REVOLADE | PROMACTA | Promacta
Molecular Formula C25H22N4O4

Additional synonyms for CHEMBL461101 found using NCI Chemical Identifier Resolver

Compound Representations

Molfile Download MolFile
Canonical SMILES CC1=NN(C(=O)/C/1=N\Nc2cccc(c2O)c3cccc(c3)C(=O)O)c4ccc(C)c(C) ...
Download SMILES
Standard InChI InChI=1S/C25H22N4O4/c1-14-10-11-19(12-15(14)2)29-24(31)22(16 ...
Download InChI
Standard InChI Key XDXWLKQMMKQXPV-QYQHSDTDSA-N

Sources

  • British National Formulary
  • Orange Book
  • Scientific Literature
  • USP Dictionary of USAN and International Drug Names
  • WHO Anatomical Therapeutic Chemical Classification

Alternate Forms of Compound in ChEMBL


CHEMBL461101

Molecule Features

CHEMBL461101 compound icon
Drug Type:Synthetic Small Molecule Rule of Five:Y First In Class:N Chirality:Achiral Molecule Prodrug:N Oral:Y Parenteral:N Topical:N Black Box:Y Availability Type:Prescription-only

Mechanism of Action

Mechanism of Action ChEMBL Target References
Thrombopoietin receptor agonist Thrombopoietin receptor DailyMed

Indications

MESH Heading MESH ID EFO ID EFO Term Max phase for indication References
Anemia, AplasticD000741HP:0001915aplastic anemia3ClinicalTrials
Hepatitis C, ChronicD019698EFO:0004220Chronic Hepatitis C infection3ClinicalTrials
Graft vs Host DiseaseD006086EFO:0004599acute graft vs. host disease2ClinicalTrials
LeukemiaD007938EFO:0000565leukemia2ClinicalTrials
AnemiaD000740EFO:0004272anemia2ClinicalTrials
Anemia, AplasticD000741EFO:0006927severe aplastic anemia4DailyMed
ClinicalTrials
Leukemia, Lymphocytic, Chronic, B-CellD015451EFO:0000095chronic lymphocytic leukemia2ClinicalTrials
Liver CirrhosisD008103EFO:0001422cirrhosis of liver1ClinicalTrials
OsteosarcomaD012516EFO:0000637osteosarcoma1ClinicalTrials
Hepatitis CD006526EFO:0003047hepatitis C infection3ClinicalTrials
Fanconi AnemiaD005199Orphanet:84Fanconi anemia2ClinicalTrials
HemorrhageD006470MP:0001914hemorrhage4ATC
NeoplasmsD009369EFO:0000616neoplasm3ClinicalTrials
Purpura, Thrombocytopenic, IdiopathicD016553EFO:0007160autoimmune thrombocytopenic purpura4DailyMed
ClinicalTrials
ThrombocytopeniaD013921HP:0001873thrombocytopenia3ClinicalTrials
Leukemia, Myeloid, AcuteD015470EFO:0000222acute myeloid leukemia2ClinicalTrials
Liver DiseasesD008107EFO:0001421liver disease2ClinicalTrials
Multiple MyelomaD009101EFO:0001378multiple myeloma0ClinicalTrials
Myelodysplastic SyndromesD009190EFO:0000198myelodysplastic syndrome2ClinicalTrials

Clinical Data

ClinicalTrials.gov ELTROMBOPAG
The Cochrane Collaboration ELTROMBOPAG

Compound Bioactivity Summary

Compound Assay Summary

Compound Target Summary

Target Predictions

The two tables below display ChEMBL single-protein targets which are predicted to interact with CHEMBL461101. A 1uM and 10 uM cut-off have been applied to ChEMBL bioactivity data used to generate the respective models and the yellow coloured rows correspond to genuine predictions, i.e. targets not included in the original training set for this compound.


1uM


ChEMBL_ID Target Name Organism Score
CHEMBL1864 Thrombopoietin receptor Homo sapiens 1.000
CHEMBL1293226 Lysine-specific demethylase 4D-like Homo sapiens 0.341

10uM


ChEMBL_ID Target Name Organism Score
CHEMBL4860 Apoptosis regulator Bcl-2 Homo sapiens 0.990
CHEMBL1864 Thrombopoietin receptor Homo sapiens 0.971
CHEMBL1075138 Tyrosyl-DNA phosphodiesterase 1 Homo sapiens 0.962
CHEMBL1741221 Cysteine protease ATG4B Homo sapiens 0.942
CHEMBL1293224 Microtubule-associated protein tau Homo sapiens 0.531
CHEMBL3864 Protein-tyrosine phosphatase 2C Homo sapiens 0.494
CHEMBL4625 Apoptosis regulator Bcl-X Homo sapiens 0.370
CHEMBL5619 DNA-(apurinic or apyrimidinic site) lyase Homo sapiens 0.352
CHEMBL1293226 Lysine-specific demethylase 4D-like Homo sapiens 0.329
CHEMBL2392 DNA polymerase beta Homo sapiens 0.303
CHEMBL4361 Induced myeloid leukemia cell differentiation protein Mcl-1 Homo sapiens 0.255
CHEMBL1293277 Niemann-Pick C1 protein Homo sapiens 0.204

Calculated Compound Parent Properties

Mol. Weight Mol. Weight Monoisotopic ALogP #Rotatable Bonds Polar Surface Area Molecular Species
442.5 442.1641 4.56 5 114.59 ACID


HBA HBD #Ro5 Violations HBA (Lipinski) HBD (Lipinski) #Ro5 Violations (Lipinski)
6 3 0 8 3 0


ACD Acidic pKa ACD Basic pKa ACD LogP ACD LogD pH7.4 Aromatic Rings Heavy Atoms QED Weighted
-1.26 - 4.71 1.39 3 33 0.4

Structural Alerts

There are 6 structural alerts for CHEMBL461101. To view alerts please click here.

Compound Cross References

ATC B - BLOOD AND BLOOD FORMING ORGANS
B02 - ANTIHEMORRHAGICS
B02B - VITAMIN K AND OTHER HEMOSTATICS
B02BX - Other systemic hemostatics
B02BX05 - eltrombopag

ChemSpider ChemSpider:XDXWLKQMMKQXPV-QYQHSDTDSA-N
DailyMed eltrombopag olamine
Wikipedia Eltrombopag

UniChem Cross References

View the UniChem Connectivity matches for CHEMBL461101



ChEBI 85010
ChemicalBook CB71463423
DrugBank DB06210
DrugCentral 4399
eMolecules 28294944
FDA SRS S56D65XJ9G
Guide to Pharmacology 6961
MolPort MolPort-006-393-918
Nikkaji J2.645.513H
PubChem: Thomson Pharma 14808156
SureChEMBL SCHEMBL211081
ZINC ZINC000011679756

UniChem REST Service Call:
https://www.ebi.ac.uk/unichem/rest/verbose_inchikey/XDXWLKQMMKQXPV-QYQHSDTDSA-N spacer
spacer